Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Becton Dickinson and Co BDX

Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, and others. Its BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, advanced monitoring solutions and pharmaceutical systems. The Company's BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. Its BD Interventional segment provides vascular, urology, oncology and surgical specialty products.


NYSE:BDX - Post by User

Post by whytestockson Aug 02, 2024 2:46pm
28 Views
Post# 36161595

Outperform Recommendation Issued On BDX By Raymond James

Outperform Recommendation Issued On BDX By Raymond James
News; $BDX Outperform Recommendation Issued On BDX By Raymond James2024-08-02 11:15:08 ET Raymond James analyst issues OUTPERFORM recommendation for BDX on August 2, 2024 09:49AM ET. The previous analyst recommendation was Outperform. BDX was trading at $239.0875 at issue of the analyst recommendation. The overall analyst consensus : BU...BDX - Outperform Recommendation Issued On BDX By Raymond James

<< Previous
Bullboard Posts